Federal health officials on Wednesday took steps to compel scientists to make clinical study results public even when the findings cut against the interest of pharmaceutical companies.. The National Institutes of Health released a proposed rule that would give federal officials more power to enforce a 2007 law that generally called for results of many medical studies to be published. The proposed rule would, for example, typically require researchers to publish later-stage studies even when the FDA doesn’t approve the drug or...
  